Literature DB >> 15469437

Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway.

Jean-Philippe Nougayrède1, Michael S Donnenberg.   

Abstract

Enteropathogenic Escherichia coli (EPEC) is a causative agent of infant diarrhoea in developing countries. The EspF protein is the product of the espF gene found on the locus of enterocyte effacement, the key pathogenicity island carried by EPEC and enterohemorrhagic E. coli. EspF is injected from adherent EPEC into host cells via a type III secretion system and was previously shown to induce apoptotic cell death and to be required for disruption of host intestinal barrier function. In this work, we show by immunofluorescence and fractionation studies that EspF is targeted to host mitochondria. The N-terminal region of EspF serves as a mitochondrial import signal and, when expressed within cells, can target hybrid green fluorescent protein to mitochondria. Assessment of mitochondrial membrane potential in infected epithelial cells indicated that EspF plays a role in the mitochondrial membrane permeabilization induced by EPEC infection. Furthermore, EspF was associated with the release of cytochrome c from mitochondria into the cytoplasm and with caspase-9 and caspase-3 cleavage. These findings indicate a role for EspF in initiating the mitochondrial death pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15469437     DOI: 10.1111/j.1462-5822.2004.00421.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  75 in total

Review 1.  Bacteria and host interactions in the gut epithelial barrier.

Authors:  Hiroshi Ashida; Michinaga Ogawa; Minsoo Kim; Hitomi Mimuro; Chihiro Sasakawa
Journal:  Nat Chem Biol       Date:  2011-12-15       Impact factor: 15.040

2.  The type III system-secreted effector EspZ localizes to host mitochondria and interacts with the translocase of inner mitochondrial membrane 17b.

Authors:  Stephanie R Shames; Matthew A Croxen; Wanyin Deng; B Brett Finlay
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

Review 3.  Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms.

Authors:  Lila G Glotfelty; Gail A Hecht
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

Review 4.  Interactions between bacterial pathogens and mitochondrial cell death pathways.

Authors:  Thomas Rudel; Oliver Kepp; Vera Kozjak-Pavlovic
Journal:  Nat Rev Microbiol       Date:  2010-09-06       Impact factor: 60.633

5.  The EspF effector, a bacterial pathogen's Swiss army knife.

Authors:  Ashleigh Holmes; Sabrina Mühlen; Andrew J Roe; Paul Dean
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

Review 6.  Targeting of host organelles by pathogenic bacteria: a sophisticated subversion strategy.

Authors:  Pedro Escoll; Sonia Mondino; Monica Rolando; Carmen Buchrieser
Journal:  Nat Rev Microbiol       Date:  2015-11-23       Impact factor: 60.633

Review 7.  Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.

Authors:  Junkal Garmendia; Gad Frankel; Valérie F Crepin
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

8.  EspF of enteropathogenic Escherichia coli binds sorting nexin 9.

Authors:  Oliver Marchès; Miranda Batchelor; Robert K Shaw; Amit Patel; Nicola Cummings; Takeshi Nagai; Chihiro Sasakawa; Sven R Carlsson; Richard Lundmark; Celine Cougoule; Emmanuelle Caron; Stuart Knutton; Ian Connerton; Gad Frankel
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

Review 9.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 10.  Exploitation of eukaryotic subcellular targeting mechanisms by bacterial effectors.

Authors:  Stuart W Hicks; Jorge E Galán
Journal:  Nat Rev Microbiol       Date:  2013-05       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.